Edelweiss Small Cap Fund
The scheme seeks to generate long term capital appreciation from a portfolio that predominantly invests in equity and equity related securities of small cap companies.
Growthvine rating: 4/5 — ranked #6 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹45.74 (as of 2026-10-01) |
|---|
| AUM | ₹7,253 Cr |
|---|
| Expense ratio | 1.54% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Dhruv Bhatia |
|---|
| Exit load | 1% for redemption within 90 days |
|---|
Performance & risk
| 5-year annualised return | 14.32% |
|---|
| Sharpe ratio | 0.58 |
|---|
| Standard deviation | 18.06% |
|---|
| Max drawdown | −37.18% |
|---|
| Alpha | 2.28 |
|---|
| Beta | 0.81 |
|---|
Over 5 years, captured 83.8% of NIFTY Smallcap 250's upside and 73.8% of its downside.
Market cap allocation
| Large cap | 5.6% |
|---|
| Mid cap | 23.1% |
|---|
| Small cap | 71.3% |
|---|
Concentration
| Top 5 holdings | 13.1% |
|---|
| Top 10 holdings | 23.0% |
|---|
| Total holdings | 95 |
|---|
| Index overlap | 23.0% |
|---|
| Active share | 77.0% |
|---|
Top holdings
- City Union Bank Ltd — 3.2%
- Karur Vysya Bank Ltd. — 2.6%
- Multi Commodity Exchange of India Ltd — 2.6%
- PNB Housing Finance Limited — 2.3%
- Avalon Technologies Limited — 2.3%
- Gabriel India Ltd. — 2.2%
- KEI Industries Ltd. — 2.1%
- Ajanta Pharma Ltd. — 1.9%
- Fortis Healthcare Ltd — 1.9%
- Radico Khaitan Ltd. — 1.8%
Top sectors
- Banking & Financial — 16.7%
- Automobile — 12.0%
- Pharma & Biotech — 8.6%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 4.1% | Q4 (Bottom) | #32 of 34 |
| 2025 | −2.4% | Q2 | #10 of 30 |
| 2024 | 24.9% | Q3 | #16 of 28 |
| 2023 | 42.1% | Q2 | #12 of 24 |
| 2022 | 1.7% | Q2 | #10 of 22 |